Sage Journals: Discover world-class research

Retricted access

Review article

First published 2018-6

Betrixaban: A Novel Oral Anticoagulant With a New Niche

Grazia Murphy, Yasmin Grace, Sadaf Chaudry [...]

Journal of Pharmacy Technology

Free access

Research article

First published 2015-9

A Facile Method for the Synthesis of Betrixaban

Jianye Li, Ligong Chen, Xilong Yan [...]

Journal of Chemical Research

Retricted access

Review article

First published 2018-6

Betrixaban: A New Oral Factor Xa Inhibitor for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients

Scott G. Garland, Christina E. DeRemer, Steven M. Smith [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2025-6

Predicting drug–drug interactions and optimal dosing of betrixaban with physiologically based pharmacokinetic modeling in patients with renal impairment who were coadministered with P-glycoprotein inhibitors

Xiaoping Yan, Lirong Xiao, Weina Xie

Journal of International Medical Research

Open access

Research article

First published 2022

Differential Neutralization of Apixaban,Betrixaban,Edoxaban,and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis

Siddharth Mehrotra, Debra Hoppensteadt, Walter Jeske [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Review article

First published 2018-2

Formulary Drug Review: Betrixaban

Danial E. Baker

Hospital Pharmacy

Open access

Research article

First published 2019

Factor Xa Inhibitory Profile of Apixaban,Betrixaban,Edoxaban,and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

Fakiha Siddiqui, Debra Hoppensteadt, Walter Jeske [...]

Clinical and Applied Thrombosis/Hemostasis

Free access

Editorial

First published 2017-10

Betrixaban for VTE Prevention in the Medically Ill Population,the APEX Trial: Good News for This Needy Population?

Eduardo Ramacciotti, Debra Hoppensteadt, Jawed Fareed

Clinical and Applied Thrombosis/Hemostasis

Free access

Review article

First published 2019-3

Approaches to Direct Oral Anticoagulant Selection in Practice

Bridget Paravattil, Hazem Elewa

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Research article

First published 2019

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values

Fakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti [...]

Clinical and Applied Thrombosis/Hemostasis

Search results